Accessibility: Skip TopNav
Sam Backenroth, Chief Financial Officer, VBL Therapeutics
Sam Backenroth, Chief Financial Officer, VBL Therapeutics
Format
JPEG
Quelle:
Vascular Biogenics Ltd.
Downloads
Originalgröße
Groß
Mittel
Klein